Passage Bio Inc share price logo

Passage Bio Inc

NASDAQ: PASG

Small Cap

$4.30

-0.27

(-5.91%)

as on

Passage Bio Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.26
    $4.57
    downward going graph

    0.93%

    Downside

    6.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.26
    $20.00
    downward going graph

    0.93%

    Downside

    365.12%

    Upside

    downward going graph

Passage Bio Inc share price movements today

Previous Close
$4.57
Open
$4.50
Volume
659.3K
Day's Low - High
$4.26 - $4.57
52 Week Low - High
$4.26 - $20.00

Passage Bio Inc Historical Returns

1 Month Return
-51.26 %
3 Month Return
-55.1 %
1 Year Return
-36.85 %
3 Year Return
-79.27 %
5 Year Return
-98.71 %

Passage Bio Inc Stock Fundamentals & Key Indicators

Check Passage Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.7M

EPS (TTM)

-10.312

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-42.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-113.78%

Passage Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Passage Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$14.7M-98.71%NA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Passage Bio Inc Stock including INR - Dollar returns

The Passage Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Passage Bio Inc investment value today

Current value as on today

₹71,899

Returns

-₹28,101

(-28.1%)

Returns from Passage Bio Inc Stock

-₹36,391 (-36.39%)

Dollar Impact

₹8,290 (+8.29%)

Analyst Recommendation on Passage Bio Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Passage Bio Inc. Average target price of $11.4

Passage Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Passage Bio Inc.

What analysts predicted

62.28%UPSIDE

Target Price

$11.4

Current Price

$4.3

Analyzed by

11 Analysts

Target

$11.40

Passage Bio Inc target price $11.4, a slight upside of 62.28% compared to current price of $4.3. According to 11 analysts rating.

Passage Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Passage Bio Inc Stock has increased by 128% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:128% versus previous 30 day period

Passage Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
5
-
-
-
3
-
-
-
-
Gross Profit
-1
5
0
0
0
0
0
0
-
0
Operating Income
-28
-18
-18
-17
-20
-14
-16
-10
-8
-7
EBITDA
-22
-17
-17
-16
-15
-12
-13
-9
-7
-10
Interest Expense
-
1
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-16
-16
-15
-19
-12
-15
-9
-7
-12
Income Tax Expense
0
3
0
-
-
-
-
-
-
-
Net Income
-27
-16
-16
-15
-19
-12
-15
-9
-7
-12
Net Profit Margin
0.00%
-283.46%
0.00%
0.00%
0.00%
-396.17%
0.00%
0.00%
0.00%
0.00%

Passage Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-1
-3
-3
-3
0
Operating Income
-13
-37
-112
-185
-138
-100
-70
-43
EBITDA
-7
-36
-111
-176
-131
-98
-62
-42
Interest Expense
0
8
0
0
2
-
-
-
Depreciation
-
0
0
1
3
3
3
0
Income Before Tax
-12
-45
-112
-185
-136
-102
-64
-45
Income Tax Expense
0
8
0
6
0
5
0
-
Net Income
-12
-45
-112
-185
-136
-102
-64
-45
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Passage Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-16
-16
-15
-19
-12
-15
-9
-7
-12
Operating Cash Flow
-19
-18
-13
-7
-8
-13
-6
-4
-6
Investing Cash Flow
7
25
1
14
13
39
0
-
1
Financing Cash Flow
0
8
0
-
0
-
0
-
0
Change in Cash
-11
15
-12
7
5
25
-5
-4
-6

Passage Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-45
-112
-185
-136
-102
-64
-45
Operating Cash Flow
-39
-80
-126
-118
-78
-47
-31
Investing Cash Flow
-1
-172
-45
25
65
54
40
Financing Cash Flow
175
228
166
-1
0
8
0
Change in Cash
134
-23
-6
-94
-12
15
8

Global Institutional Holdings in Passage Bio Inc

Funds
Holdings
Lynx1 Capital Management, LP
19.44%
Acadian Asset Management LLC
0.8%
Millennium Management LLC
0.21%
Eversept Partners, LP
3.94%
JPMorgan Chase & Co
0%

Insights on Passage Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Passage Bio Inc has experienced a drawdown of -79.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 71.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 62.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PASG stock has moved down by -20.2%

About Passage Bio Inc

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
OrganisationPassage Bio Inc
HeadquartersOne Commerce Square, Philadelphia, PA, United States, 19103
IndustryBiotechnology
CEODr. William Chou M.D.
E-voting on sharesClick here to vote

Key Management of Passage Bio Inc

Name

Title

Dr. Sue Browne Ph.D.

Chief Scientific Officer

Mr. Stuart M. Henderson

Chief Business Officer

Mr. Eden Fucci

Senior Vice President of Technical Operations

Dr. Karl Whitney Ph.D.

Senior Vice President of Global Regulatory Affairs

Dr. William Chou M.D.

President, CEO & Director

Ms. Kathleen Borthwick

Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer

FAQs

What is Passage Bio Inc share price today?

Passage Bio Inc share price today is $4.3 as on at the close of the market. Passage Bio Inc share today touched a day high of $4.57 and a low of $4.26.

What is the 52 week high and 52 week low for Passage Bio Inc share?

Passage Bio Inc share touched a 52 week high of $20 on and a 52 week low of $4.26 on . Passage Bio Inc stock price today i.e. is closed at $4.3,which is 78.50% down from its 52 week high and 0.94% up from its 52 week low.

What is Passage Bio Inc's market capitalisation today?

Passage Bio Inc market capitalisation is $0.00T as on .

How to invest in Passage Bio Inc Stock (PASG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Passage Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Passage Bio Inc Shares that will get you 0.3488 shares as per Passage Bio Inc share price of $4.3 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Passage Bio Inc Stock (PASG) from India?

Indian investors can start investing in Passage Bio Inc (PASG) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Passage Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Passage Bio Inc share’s latest price of $4.3 as on May 6, 2026 at 1:29 am IST, you will get 2.3256 shares of Passage Bio Inc. Learn more about fractional shares .

What are the returns that Passage Bio Inc has given to Indian investors in the last 5 years?

Passage Bio Inc stock has given -98.71% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?